Analytical Validation of an Immunohistochemical 7-Biomarker Prognostic Assay (immunoprint<sup>®</sup>) for Early-Stage Cutaneous Melanoma in Archival Tissue of Patients with AJCC v8 T2–T3 Disease

Analytical Validation of an Immunohistochemical 7-Biomarker Prognostic Assay (immunoprint<sup>®</sup>) for Early-Stage Cutaneous Melanoma in Archival Tissue of Patients with AJCC v8 T2–T3 Disease

Selected patients with early-stage melanoma have a “hidden high risk” of poor oncologic outcomes. They might benefit from clinical trials, and ultimately, if warranted by trial results, judicious everyday use of adjuvant therapy. A promising tool to identify these individuals is the immunoprint<s...

Full description

Bibliographic Details
Main Authors: Mirjana Ziemer, Beate Weidenthaler-Barth, Philipp Gussek, Maja Pfeiffer, Johannes Kleemann, Katrin Bankov, Peter J. Wild, Silke Seibold, Priyavathi Sureshkumar, Patricia Nickel, Anton Strobel, Markus Werner, Stephan Grabbe
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Diagnostics
Subjects:
cutaneous melanoma
7-marker signature prognostic assay (immunoprint<sup>®</sup>)
risk stratification
immunohistochemistry
analytical validation
reproducibility
Online Access:https://www.mdpi.com/2075-4418/13/19/3096

Internet

https://www.mdpi.com/2075-4418/13/19/3096

Similar Items